Trends in United States Drug Shortages for Medications Used in Gastroenterology
نویسندگان
چکیده
منابع مشابه
The impact of anti-infective drug shortages on hospitals in the United States: trends and causes.
Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may l...
متن کاملHealth System Reform in the United States
In 2010, the United States adopted its first-ever comprehensive set of health system reforms in the Affordable Care Act (ACA). Implementation of the law, though politically contentious and controversial, has now reached a stage where reversal of most elements of the law is no longer feasible. The controversial portions of the law that expand affordable health insurance coverage to most U.S. cit...
متن کاملCorrection: Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
[This corrects the article DOI: 10.1371/journal.pone.0134597.].
متن کاملImpact of Drug Shortages on Health System Pharmacies in the Southeastern United States.
BACKGROUND Drug shortages have become all too common and affect all aspects of the health care delivery system. The increased number of drug shortages has had a negative impact on patient care as well as costly financial implications. OBJECTIVES This article identifies the current problems and negative outcomes drug shortages have caused and provides a framework for how to best prepare for an...
متن کاملChemotherapy drug shortages in the United States: genesis and potential solutions.
In October 2011, the US Food and Drug Administration (FDA) announced the end of the cytarabine shortage. Cytarabine is the key chemotherapy drug for the management of leukemia in children and adults, particularly acute myeloid leukemia, and the announcement by the FDA of an end to this 11-month crisis was good news. However, in July 2011, we started experiencing shortages of daunorubicin, anoth...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine Access @ Point of Care
سال: 2017
ISSN: 2399-2026,2399-2026
DOI: 10.5301/maapoc.0000012